0 125

Cited 0 times in

Which is your choice? Neoadjuvant Adriamycin and Docetaxel (AD) versus Adriamycin, Cyclophosphamide and Paclitaxel (ACT) in locally advanced breast cancer

Authors
Kim, Ku Sang; Hong, Woo Sung; Jung, Yong Sik; Kim, Ji Young; Kang, Seok Youn
Department
Breast Cancer Center
Appears in Collections:
Others > Poster > Poster
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse